ACCLARIS HOLDINGS
Acclaris Holdings, Inc. offers software that focuses to administer healthcare programs. The company was incorporated in 2001 and is based in Tampa, Florida. The company delivers financial technology and integrated services to manage FSA, HRA, HSA plans and more.
ACCLARIS HOLDINGS
Industry:
Health Care Information Technology Software
Founded:
2001-01-01
Address:
Tampa, Florida, United States
Country:
United States
Website Url:
http://www.acclaris.com
Total Employee:
501+
Status:
Closed
Contact:
(813) 873-2020
Total Funding:
17 M USD
Technology used in webpage:
SPF Domain Not Resolving Microsoft Exchange Online Office 365 Mail ReCAPTCHA Microsoft Azure DNS GStatic Google Static Content Proofpoint Ninja Forms Salesforce SPF
Current Advisors List
Current Employees Featured
Founder
Investors List
Staley Capital
Staley Capital investment in Private Equity Round - Acclaris Holdings
Trident Capital
Trident Capital investment in Private Equity Round - Acclaris Holdings
HarbourVest Partners
HarbourVest Partners investment in Private Equity Round - Acclaris Holdings
Updata Ventures Partners
Updata Ventures Partners investment in Private Equity Round - Acclaris Holdings
Escalate Capital Partners
Escalate Capital Partners investment in Series A - Acclaris Holdings
MMV Capital Partners
MMV Capital Partners investment in Venture Round - Acclaris Holdings
Updata Partners
Updata Partners investment in Series A - Acclaris Holdings
Official Site Inspections
http://www.acclaris.com
- Host name: 129.80.151.49
- IP address: 129.80.151.49
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Acclaris Holdings"
HOME - ACLARIS
ACLARIS – water filters WE ARE THE “CREATORS OF FINE WATERS”. Your knowledge hub for water filters and mineralization technologies Providing customized purification solutions for hot and cold water applications is one of …See details»
HOME - ACLARIS
Aclaris – Wasserfilter WIR SIND DIE „CREATORS OF FINE WATERS“. Das Kompetenzzentrum für Wasserfilter und Mineralisierung KUNDENSPEZIFISCHE LÖSUNGEN FÜR KALT- UND HEISSWASSER SIND UNSERE …See details»
ABOUT US - ACLARIS
About us CREATORS OF FINE WATERS FOR OVER 25 YEARS ACLARIS is an internationally renowned specialist in water tank purification solutions for fully automatic coffee machines. We …See details»
Home | Aclaris Therapeutics Inc.
Feb 12, 2025 Welcome to Aclaris, a biopharmaceutical company that strives to translate scientific discovery into everyday victories in immuno-inflammatory conditions. Find out more » Recent updates. Mar 04, 2025. Aclaris …See details»
Confluence Discovery Technologies | Drug Discovery …
Full Service Drug Discovery Contract Research Organization (CRO) Confluence Discovery Technologies, Inc., an indirectly wholly owned subsidiary of Aclaris Therapeutics, Inc., serves as research partners for pharma and biotech …See details»
Aclaris Therapeutics - Crunchbase Company Profile
Aclaris Therapeutics started by the founders of Vicept Therapeutics, is a privately held specialty pharmaceutical dermatology company focused on the development of novel dermatologic therapies. It is committed to identifying, developing, and …See details»
Leadership | Aclaris Therapeutics Inc.
Prior to Aclaris, he co-founded and served as President and Chief Executive Officer and a member of the board of directors of Vicept Therapeutics, Inc., a dermatology-focused specialty …See details»
Aclaris Therapeutics - Funding, Financials, Valuation
Aclaris Therapeutics is registered under the ticker NASDAQ:ACRS . Aclaris Therapeutics is funded by 16 investors. Decheng Capital and Adage Capital Management are the most recent investors. Aclaris Therapeutics has acquired …See details»
Board of Directors | Aclaris Therapeutics Inc.
He has served as a member of Aclaris’ board of directors since 2014. Since 2010, Mr. Molineaux has served as President and Chief Executive Officer of Life Sciences Pennsylvania, formerly …See details»
Corporate Overview - investor.aclaristx.com
COPD, asthma or other indications, the development of Aclaris’ drug candidates, including BSI -045B, BSI-502, ATI -2138 and an undisclosed next generation selective ITK inhibitor, the …See details»
Aclaris Therapeutics - Org Chart, Teams, Culture & Jobs …
Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options. …See details»
ACLARIS MOVES INTO ITS NEW HEADQUARTERS IN REBSTEIN
5 days ago ACLARIS’s new headquarters building at its Rebstein (Switzerland) location allows the company to accommodate its steady growth and bring several departments together under …See details»
Acclaris Holdings - Crunchbase Company Profile & Funding
Acclaris Holdings, Inc. offers software that focuses to administer healthcare programs. The company was incorporated in 2001 and is based in Tampa, Florida.See details»
Aclaris Therapeutics Announces Leadership Changes and Strategic ...
Jan 16, 2024 Aclaris Therapeutics, Inc. - Douglas Manion, M.D. to step down as Chief Executive Officer, President and Member of Board of Directors - - Dr. Neal Walker, Current Chairman …See details»
Acclaris - 2025 Company Profile, Funding & Competitors - Tracxn
Mar 20, 2025 Acclaris - Managing consumer-driven healthcare. Acquired by Willis Towers Watson. Raised a total funding of $53.1M over 6 rounds from 11 investors. Founded by …See details»
Overview | Aclaris Therapeutics Inc.
Aclaris operates Confluence Discovery Technologies, Inc., a full-service drug discovery and early development contract research organization.. Confluence serves as a research partner for …See details»
Acclaris, Inc. Company Profile | Overland Park, KS - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for ACCLARIS, INC. of Overland Park, KS. Get the latest business insights from Dun & Bradstreet.See details»
Acclaris - Overview, News & Similar companies | ZoomInfo.com
Who is Acclaris. Acclaris provides the technology and services that health plans, benefit consultants, private exchanges and financial institutions rely on to deliv er health care and …See details»
Aclaris Support | Aclaris Therapeutics Inc.
Aclaris will consider unsolicited research proposals submitted electronically by external investigators interested in studying our investigational drug candidates in therapeutic areas of …See details»
Will Aclaris Therapeutics (NASDAQ:ACRS) Spend Its Cash Wisely?
2 days ago In December 2024, Aclaris Therapeutics had US$114m in cash, and was debt-free. Looking at the last year, the company burnt through US$56m. That means it had a cash …See details»